Pharmacology, toxicity and pharmacokinetics of acetylshikonin: a review.
CONCLUSIONS: Although experimental data supports the beneficial effects of this compound, acetylshikonin cannot be considered as a therapy drug without further investigations, especially, on the toxicity and pharmacokinetics.
PMID: 32956595 [PubMed - in process]
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Tags: Pharm Biol Source Type: research
More News: Biology | Brain | Databases & Libraries | Drugs & Pharmacology | Neurology | Neuroscience | Science | Study | Toxicology